http://www.natap.org/2013/APASL/APASL_30.htm
Six Years of Treatment With Tenofovir DF for Chronic Hepatitis B Virus Infection is Safe and Well Tolerated and Associated With Sustained Virological, Biochemical, and Serological Responses With No Detectable Resistance
Reported by Jules Levin
Asian Pacific Association for the Study of the Liver (APASL) Liver Week, June
6-10, 2013, Singapore
Naoky Tsai1, Maria Buti2, Edward Gane3, William Sievert4, Ira M. Jacobson5, Phillip Dinh6, John F.